234 related articles for article (PubMed ID: 21226278)
1. [Roles of angiopoietin-like protein 2 (Angptl2) in chronic inflammation and atherosclerotic diseases].
Oike Y
Nihon Rinsho; 2011 Jan; 69(1):163-7. PubMed ID: 21226278
[TBL] [Abstract][Full Text] [Related]
2. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.
Horio E; Kadomatsu T; Miyata K; Arai Y; Hosokawa K; Doi Y; Ninomiya T; Horiguchi H; Endo M; Tabata M; Tazume H; Tian Z; Takahashi O; Terada K; Takeya M; Hao H; Hirose N; Minami T; Suda T; Kiyohara Y; Ogawa H; Kaikita K; Oike Y
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):790-800. PubMed ID: 24526691
[TBL] [Abstract][Full Text] [Related]
3. Angiopoietin-like proteins: emerging targets for treatment of obesity and related metabolic diseases.
Kadomatsu T; Tabata M; Oike Y
FEBS J; 2011 Feb; 278(4):559-64. PubMed ID: 21182596
[TBL] [Abstract][Full Text] [Related]
4. Angiopoietin-like proteins--potential therapeutic targets for metabolic syndrome and cardiovascular disease.
Oike Y; Tabata M
Circ J; 2009 Dec; 73(12):2192-7. PubMed ID: 19875897
[TBL] [Abstract][Full Text] [Related]
5. Clinical implications of the metabolic syndrome.
Ceska R
Diab Vasc Dis Res; 2007 Sep; 4 Suppl 3():S2-4. PubMed ID: 17935057
[TBL] [Abstract][Full Text] [Related]
6. Targeting systemic inflammation in metabolic disorders. A therapeutic candidate for the prevention of cardiovascular diseases?
Domingo E; Marques P; Francisco V; Piqueras L; Sanz MJ
Pharmacol Res; 2024 Feb; 200():107058. PubMed ID: 38218355
[TBL] [Abstract][Full Text] [Related]
7. Optimal risk factor modification and medical management of the patient with peripheral arterial disease.
Chi YW; Jaff MR
Catheter Cardiovasc Interv; 2008 Mar; 71(4):475-89. PubMed ID: 18307227
[TBL] [Abstract][Full Text] [Related]
8. Diverse roles of ANGPTL2 in physiology and pathophysiology.
Kadomatsu T; Endo M; Miyata K; Oike Y
Trends Endocrinol Metab; 2014 May; 25(5):245-54. PubMed ID: 24746520
[TBL] [Abstract][Full Text] [Related]
9. Endothelial dysfunction in obesity: etiological role in atherosclerosis.
Meyers MR; Gokce N
Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):365-9. PubMed ID: 17940464
[TBL] [Abstract][Full Text] [Related]
10. Association of serum angiopoietin-like protein 2 with carotid intima-media thickness in subjects with type 2 diabetes.
Jung CH; Lee WJ; Lee MJ; Kang YM; Jang JE; Leem J; La Lee Y; Seol SM; Yoon HK; Park JY
Cardiovasc Diabetol; 2015 Apr; 14():35. PubMed ID: 25889082
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome, inflammation and atherosclerosis.
Paoletti R; Bolego C; Poli A; Cignarella A
Vasc Health Risk Manag; 2006; 2(2):145-52. PubMed ID: 17319458
[TBL] [Abstract][Full Text] [Related]
12. [Prevention of cardiovascular disease in patients with type 2 diabetes].
Lebherz C; Lehrke M
Dtsch Med Wochenschr; 2015 Apr; 140(9):645-9. PubMed ID: 25924043
[TBL] [Abstract][Full Text] [Related]
13. [Chronic mild inflammation links obesity, metabolic syndrome, atherosclerosis and diabetes].
Andel M; Polák J; Kraml P; Dlouhý P; Stich V
Vnitr Lek; 2009; 55(7-8):659-65. PubMed ID: 19731872
[TBL] [Abstract][Full Text] [Related]
14. [Guidelines for the management of atherosclerotic diseases in diabetes mellitus].
Kotake H; Oikawa S
Nihon Rinsho; 2006 Nov; 64(11):2074-80. PubMed ID: 17087299
[TBL] [Abstract][Full Text] [Related]
15. The role of angiopoietin-like protein 2 in pathogenesis of dermatomyositis.
Ogata A; Endo M; Aoi J; Takahashi O; Kadomatsu T; Miyata K; Tian Z; Jinnin M; Fukushima S; Ihn H; Oike Y
Biochem Biophys Res Commun; 2012 Feb; 418(3):494-9. PubMed ID: 22281496
[TBL] [Abstract][Full Text] [Related]
16. Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance.
Tabata M; Kadomatsu T; Fukuhara S; Miyata K; Ito Y; Endo M; Urano T; Zhu HJ; Tsukano H; Tazume H; Kaikita K; Miyashita K; Iwawaki T; Shimabukuro M; Sakaguchi K; Ito T; Nakagata N; Yamada T; Katagiri H; Kasuga M; Ando Y; Ogawa H; Mochizuki N; Itoh H; Suda T; Oike Y
Cell Metab; 2009 Sep; 10(3):178-88. PubMed ID: 19723494
[TBL] [Abstract][Full Text] [Related]
17. Examination of lower targets for low-density lipoprotein cholesterol and blood pressure in diabetes--the Stop Atherosclerosis in Native Diabetics Study (SANDS).
Russell M; Fleg JL; Galloway WJ; Henderson JA; Howard J; Lee ET; Poolaw B; Ratner RE; Roman MJ; Silverman A; Stylianou M; Weir MR; Wilson C; Yeh F; Zhu J; Howard BV
Am Heart J; 2006 Nov; 152(5):867-75. PubMed ID: 17070147
[TBL] [Abstract][Full Text] [Related]
18. [Management of diabetes in cardiac diseases].
Işik S; Delibaşi T; Berker D; Aydin Y; Güler S
Anadolu Kardiyol Derg; 2009 Jun; 9(3):238-47. PubMed ID: 19520659
[TBL] [Abstract][Full Text] [Related]
19. ANGPTL2 promotes tumor metastasis in hepatocellular carcinoma.
Gao L; Ge C; Fang T; Zhao F; Chen T; Yao M; Li J; Li H
J Gastroenterol Hepatol; 2015 Feb; 30(2):396-404. PubMed ID: 25090954
[TBL] [Abstract][Full Text] [Related]
20. Serum Angiopoietin-Like Protein 2 Concentrations Are Independently Associated with Heart Failure.
Huang CL; Wu YW; Wu CC; Hwang JJ; Yang WS
PLoS One; 2015; 10(9):e0138678. PubMed ID: 26397985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
